Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile

BACKGROUND: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and lipid metabolism in animal models. The relationship between plasma levels of FGF-21 and coronary heart disease (CHD) in unknown. METHODOLOGY/PRINCIPAL FINDINGS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhuofeng, Wu, Zhen, Yin, Xiaojing, Liu, Yanlong, Yan, Xinxin, Lin, Shaoqiang, Xiao, Jian, Wang, Xiaojie, Feng, Wenke, Li, Xiaokun
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012070/
https://www.ncbi.nlm.nih.gov/pubmed/21206918
http://dx.doi.org/10.1371/journal.pone.0015534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012070/
https://www.ncbi.nlm.nih.gov/pubmed/21206918
http://dx.doi.org/10.1371/journal.pone.0015534

Ejemplares similares